These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 29771450)

  • 1. Effects of intense aerobic exercise and/or antihypertensive medication in individuals with metabolic syndrome.
    Ramirez-Jimenez M; Morales-Palomo F; Ortega JF; Mora-Rodriguez R
    Scand J Med Sci Sports; 2018 Sep; 28(9):2042-2051. PubMed ID: 29771450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-exercise Hypotension Produced by Supramaximal Interval Exercise is Potentiated by Angiotensin Receptor Blockers.
    Ramirez-Jimenez M; Morales-Palomo F; Ortega JF; Mora-Rodriguez R
    Int J Sports Med; 2019 Nov; 40(12):756-761. PubMed ID: 31476782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of statin therapy and exercise on postprandial triglycerides in overweight individuals with hypercholesterolaemia.
    Mora-Rodriguez R; Ortega JF; Morales-Palomo F; Ramirez-Jimenez M; Moreno-Cabañas A
    Br J Clin Pharmacol; 2020 Jun; 86(6):1089-1099. PubMed ID: 31925809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of antihypertensive medication and high-intensity interval training in hypertensive metabolic syndrome individuals.
    Ramirez-Jimenez M; Morales-Palomo F; Moreno-Cabañas A; Alvarez-Jimenez L; Ortega JF; Mora-Rodriguez R
    Scand J Med Sci Sports; 2021 Jul; 31(7):1411-1419. PubMed ID: 33662166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intense aerobic exercise lowers blood pressure in individuals with metabolic syndrome taking antihypertensive medicine.
    Ramirez-Jimenez M; Fernandez-Elias V; Morales-Palomo F; Ortega JF; Mora-Rodriguez R
    Blood Press Monit; 2018 Oct; 23(5):230-236. PubMed ID: 29768290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
    Shimada K; Ogihara T; Saruta T; Kuramoto K;
    Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: impact on the early morning period.
    White WB; Lacourciere Y; Davidai G
    Am J Hypertens; 2004 Apr; 17(4):347-53. PubMed ID: 15062889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ambulatory blood pressure response to a bout of HIIT in metabolic syndrome patients.
    Ramirez-Jimenez M; Morales-Palomo F; Pallares JG; Mora-Rodriguez R; Ortega JF
    Eur J Appl Physiol; 2017 Jul; 117(7):1403-1411. PubMed ID: 28493030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nebivolol monotherapy for patients with systolic stage II hypertension: results of a randomized, placebo-controlled trial.
    Lewin A; Punzi H; Luo X; Stapff M
    Clin Ther; 2013 Feb; 35(2):142-52. PubMed ID: 23332366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Add-on angiotensin receptor blockade with maximized ACE inhibition.
    Agarwal R
    Kidney Int; 2001 Jun; 59(6):2282-9. PubMed ID: 11380832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the renin inhibitor MK-8141 (ACT-077825) in patients with hypertension.
    Jones-Burton C; Rubino J; Roy S; Mai Y; Meehan A; Bellet M; Feig P
    J Am Soc Hypertens; 2010; 4(5):219-26. PubMed ID: 20705534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y; Neutel JM; Schumacher H
    Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on blood pressure in nondiabetic patients with mild to moderate hypertension.
    Mistry GC; Maes AL; Lasseter KC; Davies MJ; Gottesdiener KM; Wagner JA; Herman GA
    J Clin Pharmacol; 2008 May; 48(5):592-8. PubMed ID: 18353996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of once-daily oral fimasartan 20 to 240 mg/d in Korean Patients with hypertension: findings from Two Phase II, randomized, double-blind, placebo-controlled studies.
    Lee H; Yang HM; Lee HY; Kim JJ; Choi DJ; Seung KB; Jeon ES; Ha JW; Rim SJ; Park JB; Shin JH; Oh BH
    Clin Ther; 2012 Jun; 34(6):1273-89. PubMed ID: 22608107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients.
    Gradman AH; Schmieder RE; Lins RL; Nussberger J; Chiang Y; Bedigian MP
    Circulation; 2005 Mar; 111(8):1012-8. PubMed ID: 15723979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension.
    Germino FW
    Clin Ther; 2009 Sep; 31(9):1946-56. PubMed ID: 19843484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Losartan/hydrochlorothiazide combination therapy surpasses high-dose angiotensin receptor blocker in the reduction of morning home blood pressure in patients with morning hypertension.
    Hanayama Y; Uchida HA; Nakamura Y; Makino H
    Acta Med Okayama; 2012; 66(6):449-59. PubMed ID: 23254579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of aerobic dance training on blood pressure in individuals with uncontrolled hypertension on two antihypertensive drugs: a randomized clinical trial.
    Maruf FA; Akinpelu AO; Salako BL; Akinyemi JO
    J Am Soc Hypertens; 2016 Apr; 10(4):336-45. PubMed ID: 26948962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endurance Exercise Training reduces Blood Pressure according to the Wilder's Principle.
    Mora-Rodriguez R; Ortega JF; Morales-Palomo F; Ramirez-Jimenez M; Moreno-Cabañas A; Alvarez-Jimenez L
    Int J Sports Med; 2022 Apr; 43(4):336-343. PubMed ID: 34560789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.